Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07129109

Assessing the Performance of 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)

This cluster-randomized crossover trial evaluates the impact of two different packaging formats for small-quantity lipid-based nutrient supplements (SQ-LNS) on adherence and acceptability among caregivers of young children in Northern Ghana. SQ-LNS are a proven intervention for reducing child malnutrition, but optimizing packaging formats may improve adherence and scalability.

Sixteen health facilities participating in growth monitoring services will each receive both formats: a 1-day sachet (20g daily) and a 7-day bulk container (140g weekly), with the order of delivery randomized. Each packaging format will be distributed for one month before cross-over. The primary outcomes are adherence (measured through caregiver self-report and sachet counts) and acceptability (assessed via caregiver interviews). Secondary outcomes include caregiver preference, ease of use, and qualitative insights into feeding practices, beliefs, and packaging usability.

This implementation research study uses a convergent mixed-methods design, integrating quantitative adherence and acceptability data with in-depth interviews and structured observations to inform real-world program implementation. Findings will guide policy and program decisions for integrating SQ-LNS into child health platforms in Ghana and other low-resource settings.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Background and Rationale:

Small-quantity lipid-based nutrient supplements (SQ-LNS) have demonstrated effectiveness in reducing child undernutrition, including stunting, wasting, and anemia, particularly among children 6-24 months of age in low- and middle-income countries. Despite strong evidence, uptake and adherence in real-world settings remain suboptimal. Packaging format may influence how caregivers understand, use, and integrate SQ-LNS into daily routines.

This study, titled "Assessing the performance of 7-day vs 1-day packaging for Small Quantity Lipid-based Nutrient Supplements in Ghana," is designed to evaluate how packaging format influences adherence and acceptability when SQ-LNS are distributed through routine growth monitoring services in Northern Ghana.

Study Objectives:

Primary Objective: To compare adherence to SQ-LNS when delivered in 1-day sachets versus 7-day bulk packaging.

Secondary Objectives: To assess caregiver acceptability, preferences, ease of use, and perceptions of both packaging types; and to explore implementation facilitators and barriers to effective delivery and use of SQ-LNS within growth monitoring programs.

Study Design:

This is a cluster-randomized crossover trial embedded within routine child health services at eight health facilities. The trial follows a convergent mixed-methods implementation research design.

Clusters: Health facilities (n=16), each randomized to one of two packaging sequences.

Intervention: Each facility receives one packaging format for one month, then switches to the alternate format for another month.

Participants: Caregivers of children aged 6-24 months attending growth monitoring and promotion (GMP) services during the intervention periods.

Randomization:

Facilities are randomized to one of two sequences:

Sequence A: 1-day sachet → 7-day bulk Sequence B: 7-day bulk → 1-day sachet Randomization is stratified by facility size or service volume (if available) to ensure balance.

Sample Size:

Based on prior service utilization data and expected recruitment rates, the study aims to enroll approximately 250 caregivers per arm.

Outcomes:

Primary Outcomes: Adherence to SQ-LNS (measured by caregiver self-report, sachet count, and possibly biomarkers or stool colorant testing if available)

Secondary Outcomes:

Caregiver acceptability and preference (structured surveys and Likert scales) Usability and ease of administration Qualitative themes related to packaging, feeding practices, and caregiver experience (in-depth interviews and structured observations)

Data Collection:

Quantitative data will be collected through baseline and endline caregiver surveys, adherence logs, and observational checklists.

Qualitative data will be collected through purposive sampling of caregivers for in-depth interviews, as well as interviews with health workers and program implementers.

Analysis Plan:

Quantitative data will be analyzed using generalized linear mixed models to account for clustering and crossover design. Primary comparisons will assess differences in adherence between packaging formats. Qualitative data will be coded and analyzed thematically using a grounded theory approach. Convergence of quantitative and qualitative data will inform implementation recommendations.

Ethical Considerations:

The study will be submitted for IRB approval from received approval from Boston University and the University of Ghana. Written informed consent will be obtained from all participants. The study poses minimal risk and is embedded in routine health services.

Dissemination:

Findings will be shared with Ghana Health Service, implementing partners, and international stakeholders, and will be submitted for publication in peer-reviewed journals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary caregiver of a child aged 6-24 months attending growth monitoring and promotion (GMP) services at one of the participating health facilities
  • Willing and able to provide informed consent
  • Plans to remain in the area for the duration of the study period
  • Agrees to participate in surveys and/or interviews related to supplement use

Exclusion criteria

  • Caregiver of a child with a diagnosed severe illness requiring hospitalization
  • Caregiver under the age of 18

Treatment and study plan

small-quantity lipid-based nutrient supplements (SQ-LNS)

Dietary Supplement

All caregivers will receive 2 months of SQ-LNS in this cross-over design. Half of the participants will be randomized to receive the 7-day packaging first, and half will receive the 1-day packaging first.

Primary outcomes

  1. Adherence

    Time frame: Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase

    Adherence will be defined as the percentage of the 28-day dose of small quantity lipid-based nutrient supplements (SQ-LNS) consumed, measured using a triangulated approach that combines caregiver report with returned-sachet counts and residual-sachet weighing.

Secondary outcomes

  1. Caregiver acceptability/usability

    Time frame: Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase

    Caregiver acceptability/usability will be defined as a composite score (Likert-scaled) capturing acceptability, preference, usability, and ease of administration of the SQ-LNS packaging

  2. Caregiver experience with SQ-LNS

    Time frame: At the end of each 1-month crossover period (following each intervention phase)

    Qualitative assessment of caregiver experience with SQ-LNS, including perceptions of packaging, feeding practices, and overall acceptability, collected through semi-structured interviews and analyzed using thematic content analysis.

Study contacts

Contact information is provided by the study sponsor or research team.

Lindsey M Locks, ScD

CONTACT

[email protected]

617-353-2710

Sponsors and collaborators

Lead sponsor

Boston University Charles River Campus

Other

Collaborators

  • Edesia Nutrition
  • University of Ghana

Registry information

Official study title

Assessing the Performance of 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7Dv1D Comparison)

Acronym: SQLNS:7Dv1D

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 19, 2025
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.